Non-selective Effects of Selective Serotonin Reuptake Inhibitors

Biological Psychiatry

Volumn 63, Issue 1, 2008, Pages

  Zurowski, Bartosz ^a   Kordon, Andreas ^a   Wahl, Karina ^a   Hohagen, Fritz ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; DOPAMINE 3 RECEPTOR; FLUOXETINE; FLUVOXAMINE; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULPIRIDE;

DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SELECTIVITY; HUMAN; LETTER; NEUROTRANSMISSION; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 36849026814     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.02.028     Document Type: Letter

References (7)

1. Denys D., Fineberg N., Carey P.D., and Stein D.J. Quetiapine addition in obsessive-compulsive disorder: Is treatment outcome affected by type and dose of serotonin reuptake inhibitors?. Biol Psychiatry 61 (2007) 412-414
2. Damsa C., Bumb A., Bianchi-Demicheli F., Vidailhet P., Sterck R., Andreoli A., et al. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: A clinical review. J Clin Psychiatry 65 (2004) 1064-1068
3. Lammers C.H., Diaz J., Schwartz J.C., and Sokoloff P. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol Psychiatry 5 (2000) 378-388
4. Moresco R.M., Pietra L., Henin M., Panzacchi A., Locatelli M., Bonaldi L., et al. Fluvoxamine treatment and D2 receptors: A pet study on OCD drug-naive patients. Neuropsychopharmacology 32 (2007) 197-205
5. Zurowski B., Wahl K., Hohagen F., and Kordon A. Symptom remission in OCD after discontinuation of pharmacotherapy with fluoxetine: A case for looking beyond serotonin. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 959-960
6. Denys D., Klompmakers A.A., and Westenberg H.G. Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. Psychopharmacology 176 (2004) 195-203
7. Bell C., Abrams J., and Nutt D. Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 178 (2001) 399-405